Annual Total Debt
$15.34 M
+$1.94 M+14.44%
31 December 2023
Summary:
Castle Biosciences annual total debt is currently $15.34 million, with the most recent change of +$1.94 million (+14.44%) on 31 December 2023. During the last 3 years, it has risen by +$7.13 million (+86.94%). CSTL annual total debt is now -38.96% below its all-time high of $25.12 million, reached on 31 December 2019.CSTL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$26.74 M
+$1.55 M+6.15%
30 September 2024
Summary:
Castle Biosciences quarterly total debt is currently $26.74 million, with the most recent change of +$1.55 million (+6.15%) on 30 September 2024. Over the past year, it has increased by +$11.40 million (+74.37%). CSTL quarterly total debt is now -8.17% below its all-time high of $29.12 million, reached on 30 June 2019.CSTL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Total Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +74.4% |
3 y3 years | +86.9% | +226.0% |
5 y5 years | -39.0% | +6.4% |
CSTL Total Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +86.9% | at high | +247.7% |
5 y | 5 years | -39.0% | at high | ||
alltime | all time | -39.0% | -8.2% |
Castle Biosciences Total Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $26.74 M(+6.1%) |
June 2024 | - | $25.19 M(+0.6%) |
Mar 2024 | - | $25.05 M(+63.4%) |
Dec 2023 | $15.34 M(+14.4%) | $15.34 M(+5.6%) |
Sept 2023 | - | $14.53 M(+0.9%) |
June 2023 | - | $14.39 M(+11.7%) |
Mar 2023 | - | $12.88 M(-3.9%) |
Dec 2022 | $13.40 M(+63.4%) | $13.40 M(-0.3%) |
Sept 2022 | - | $13.44 M(+74.7%) |
June 2022 | - | $7.69 M(-2.8%) |
Mar 2022 | - | $7.91 M(-3.6%) |
Dec 2021 | $8.20 M | $8.20 M(>+9900.0%) |
Sept 2021 | - | $0.00(0.0%) |
June 2021 | - | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2021 | - | $0.00(0.0%) |
Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
Sept 2020 | - | $22.45 M(-9.2%) |
June 2020 | - | $24.74 M(-2.4%) |
Mar 2020 | - | $25.35 M(+0.9%) |
Dec 2019 | $25.12 M(+2.5%) | $25.12 M(+0.9%) |
Sept 2019 | - | $24.90 M(-14.5%) |
June 2019 | - | $29.12 M(+23.2%) |
Mar 2019 | - | $23.63 M(-3.5%) |
Dec 2018 | $24.50 M(+31.7%) | $24.50 M(>+9900.0%) |
Sept 2018 | - | $0.00(0.0%) |
June 2018 | - | $0.00(0.0%) |
Mar 2018 | - | $0.00 |
Dec 2017 | $18.60 M | - |
FAQ
- What is Castle Biosciences annual total debt?
- What is the all time high annual total debt for Castle Biosciences?
- What is Castle Biosciences quarterly total debt?
- What is the all time high quarterly total debt for Castle Biosciences?
- What is Castle Biosciences quarterly total debt year-on-year change?
What is Castle Biosciences annual total debt?
The current annual total debt of CSTL is $15.34 M
What is the all time high annual total debt for Castle Biosciences?
Castle Biosciences all-time high annual total debt is $25.12 M
What is Castle Biosciences quarterly total debt?
The current quarterly total debt of CSTL is $26.74 M
What is the all time high quarterly total debt for Castle Biosciences?
Castle Biosciences all-time high quarterly total debt is $29.12 M
What is Castle Biosciences quarterly total debt year-on-year change?
Over the past year, CSTL quarterly total debt has changed by +$11.40 M (+74.37%)